NM_025103.4:c.120+2dupT
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_025103.4(IFT74):c.120+2dupT variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000763 in 1,613,954 control chromosomes in the GnomAD database, including 1 homozygotes. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025103.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000325 AC: 81AN: 249506Hom.: 0 AF XY: 0.000295 AC XY: 40AN XY: 135374
GnomAD4 exome AF: 0.000796 AC: 1163AN: 1461748Hom.: 1 Cov.: 31 AF XY: 0.000756 AC XY: 550AN XY: 727174
GnomAD4 genome AF: 0.000447 AC: 68AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74362
ClinVar
Submissions by phenotype
Short-rib thoracic dysplasia 6 with or without polydactyly Pathogenic:1Uncertain:1
- -
- -
IFT74-related disorder Uncertain:1
The IFT74 c.120+2dupT variant is predicted to result in a duplication affecting a canonical splice site. This variant is predicted to impact the consensus donor site splicing based on available splicing prediction programs (SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751), although it does not eliminate the consensus GT donor site sequence at the junction of exon 2 and intron 2 (GT>GTT). This variant has been identified with another variant of IFT74 in a patient with Bardet-Biedl syndrome, but the phase of the variants was not established (Table S1, Schlottmann et al. 2023. PubMed ID: 37217489). This variant has also been identified in the heterozygous state in one patient with an autosomal recessive skeletal ciliopathy known as short rib-polydactyly syndrome type II (Table S3, Zhang et al. 2018. PubMed ID: 29068549). This variant is reported in 0.066% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
This sequence change falls in intron 2 of the IFT74 gene. It does not directly change the encoded amino acid sequence of the IFT74 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs551515830, gnomAD 0.07%). This variant has been observed in individual(s) with clinical features of IFT74-related conditions (PMID: 29068549). ClinVar contains an entry for this variant (Variation ID: 446698). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at